Dyslipidemia and hepatic steatosis were recognized as the early events of atherosclerosis; after 15-week supplementation, GTP improved the dyslipidemia and hepatic steatosis in ApoE-knockout mice. This evidence concerns the gene APOE and metabolic syndrome.